Vis enkel innførsel

dc.contributor.authorHofslundsengen, Hilde Christine
dc.contributor.authorKirmess, Melanie
dc.contributor.authorGuttormsen, Linn Stokke
dc.contributor.authorNæss, Kari-Anne Bottegård
dc.contributor.authorKefalianos, Elaina
dc.date.accessioned2021-11-29T09:53:42Z
dc.date.available2021-11-29T09:53:42Z
dc.date.created2021-11-22T13:07:07Z
dc.date.issued2021
dc.identifier.citationHofslundsengen, H., Kirmess, M., Guttormsen, L. S., Næss, K.-A. B., & Kefalianos, E. (2022). Systematic review of implementation quality of non-pharmacological stuttering intervention trials for children and adolescents. Journal of Fluency Disorders, 71.en_US
dc.identifier.issn0094-730X
dc.identifier.urihttps://hdl.handle.net/11250/2831839
dc.description.abstractPurpose This narrative systematic review in line with PRISMA guidelines aims to investigate the implementation quality of previously published group comparison clinical trials of stuttering interventions for children and adolescents (under age 18 years). Methods We searched for publications in the databases Eric, PsychInfo, PubMed and Web of Science using the search terms ‘stutt*’ or ‘stamm*’and ‘intervention’, ‘trial’ or ‘treatment’. We reviewed the implementation elements reported in studies and how these elements were used to report intervention outcomes. Results 3,017 references published between 1974–2019 were identified. All references were screened for eligibility using predefined selection criteria resulting in 21 included studies. The implementation quality details reported varied between studies. Existing studies most commonly lacked details about the support system provided to SLPs administering the interventions and monitoring of treatment fidelity both in the clinical setting and in the home environment. Support systems for participant’s parents and treatment dosage were generally well reported. Dosage was the most common implementation quality element considered in analyses of treatment effect and within discussions of findings. Conclusion Findings highlight the need for future clinical trials of stuttering interventions to closely adhere to systematic guidelines for reporting implementation quality to ensure reliability of trial outcomes. A checklist for reporting clinical trials of non-pharmacological stuttering interventions is proposed.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S0094730X21000632
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectstutteringen_US
dc.subjecttreatmenten_US
dc.subjectsystematic reviewen_US
dc.subjectimplementation qualityen_US
dc.subjectchecklisten_US
dc.titleSystematic review of implementation quality of non-pharmacological stuttering intervention trials for children and adolescentsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 The Author(s)en_US
dc.source.volume71en_US
dc.source.journalJournal of Fluency Disordersen_US
dc.identifier.doi10.1016/j.jfludis.2021.105884
dc.identifier.cristin1957289
dc.relation.projectNorges forskningsråd: 260567en_US
dc.source.articlenumber105884en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal